EarningsQ4 2025 Earnings Report

Nektar Therapeutics (ITH0) Q4 2025 Earnings Report

1 Followers

DE:ITH0 Q4 2025 EPS Results

Actual EPS-€1.58

Consensus EPS-€2.20

Beat/MissBeat by +€0.62

One Year Ago EPS€0.40

Actual Revenue€19.42M

Expected Revenue€9.07M

Beat/MissBeat by +€10.34M

YoY Revenue Growth-25.25%

QuarterQ4 2025

Date03/12/2026

TimeAfter Close

Conference CallThursday, March 12, 2026

DE:ITH0 Upcoming Earnings

Nektar Therapeutics's next earnings date is estimated for November 5, 2026, based on past reporting schedules.

DE:ITH0 Q4 2025 Earnings Call

0:00 / 0:00

No slide deck is available for this earnings event.

No earnings call summary is available for this earnings event.

Report Date	Fiscal Quarter	Forecast / EPS	Last Year's EPS	EPS YoY Change
Nov 05, 2026	2026 (Q3)	-1.87 / -	-1.665	―
Aug 13, 2026	2026 (Q2)	-1.75 / -1.10	-2.627	58.31% (+1.53)
May 07, 2026	2026 (Q1)	-1.41 / -1.62	-3.205	49.44% (+1.58)
Mar 12, 2026	2025 (Q4)	-2.20 / -1.58	0.401	-495.56% (-1.99)
Nov 06, 2025	2025 (Q3)	-2.39 / -1.66	-2.404	30.74% (+0.74)
Aug 07, 2025	2025 (Q2)	-2.70 / -2.63	-3.339	21.33% (+0.71)
May 08, 2025	2025 (Q1)	-2.28 / -3.21	-2.538	-26.32% (-0.67)
Mar 12, 2025	2024 (Q4)	-1.81 / 0.40	-2.938	113.64% (+3.34)
Nov 07, 2024	2024 (Q3)	-2.66 / -2.40	-3.205	25.00% (+0.80)
Aug 08, 2024	2024 (Q2)	-2.47 / -3.34	-3.606	7.41% (+0.27)

The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.

Beat

Missed